Page last updated: 2024-09-05

sb 203580 and Systemic Inflammatory Response Syndrome

sb 203580 has been researched along with Systemic Inflammatory Response Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dong, X; He, X; Xu, JJ	1

Other Studies

1 other study(ies) available for sb 203580 and Systemic Inflammatory Response Syndrome

Article	Year
[SB203580 reduces proinflammatory cytokine production in rats after cardiopulmonary bypass]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2009, Volume: 29, Issue:11 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cardiopulmonary Bypass; Cytokines; Imidazoles; Interleukin-1beta; Lung; Male; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Pyridines; Random Allocation; Rats; Rats, Sprague-Dawley; Systemic Inflammatory Response Syndrome; Tumor Necrosis Factor-alpha	2009

Article

Year

[SB203580 reduces proinflammatory cytokine production in rats after cardiopulmonary bypass].

Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2009, Volume: 29, Issue:11

Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cardiopulmonary Bypass; Cytokines; Imidazoles; Interleukin-1beta; Lung; Male; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Pyridines; Random Allocation; Rats; Rats, Sprague-Dawley; Systemic Inflammatory Response Syndrome; Tumor Necrosis Factor-alpha

2009